An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Postgraduate Institute of Medical Education and Research, Chandigarh, India
South Egypt Cancer Institute, Assuit, Egypt
Massachusetts General Hospital, Boston, Massachusetts, United States
Department of Anaesthesiology and Pain Medicine, Anaesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of
Guangzhou Military Region General Hospital, Department of Anesthesiology, Guangzhou, Guangdong, China
Cairo University, Cairo, Egypt
Ufuk University Hospital, Ankara, Turkey
General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China
Chinese PLA General Hospital, Beijing, Beijing, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.